Ascendis Pharma A/S vs Figs Inc — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Figs Inc trades at $14.26 (market cap $2.37B). The key difference: Ascendis Pharma A/S is far larger — about 7× Figs Inc's market cap. Which is the better fit depends on your goals.
| ASND | FIGS | |
|---|---|---|
Market Cap | $16.67B | $2.37B |
Sector | Health | Consumer Cyclical |
52-Week High | $277.18 | $17.12 |
52-Week Low | $189.74 | $6.57 |
Enterprise Value | $17.04B | $2.13B |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →